Evidence map›Paper›PMID 41032432›Full record

ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2025

[Incidence of COVID-19 in cancer patients from the HIGA Alende, Mar del Plata, Argentina, 2020-2021]

Sebastian Bienaime, Christian Ballejo, Tamara Ricardo, Juan Ignacio Irassar, Gabriel Amezqueta, Rodrigo Sabuda, Adriana Casatti, Mariana Laspada, Laura Rodriguez, Maria Antonela Alvarez and 1 more

Abstract readEnglish Abstract
In one paragraph

Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sebastian BienaimeInstituto Nacional de Epidemiología Dr. Jara. ANLIS Malbran.
Christian BallejoInstituto Nacional de Epidemiología Dr. Jara. ANLIS Malbran.
Tamara RicardoInstituto Nacional de Epidemiología Dr. Jara. ANLIS Malbran.
Juan Ignacio IrassarInstituto Nacional de Epidemiología Dr. Jara. ANLIS Malbran.
Gabriel AmezquetaInstituto Nacional de Epidemiología Dr. Jara. ANLIS Malbran.
Rodrigo SabudaInstituto Nacional de Epidemiología Dr. Jara. ANLIS Malbran.
Adriana CasattiHospital Interzonal General de Agudos Dr Oscar Alende, Mar del Plata, Argentina.
Mariana LaspadaHospital Interzonal General de Agudos Dr Oscar Alende, Mar del Plata, Argentina.
Laura RodriguezHospital Interzonal General de Agudos Dr Oscar Alende, Mar del Plata, Argentina.
Maria Antonela AlvarezInstituto Nacional del Cáncer, Ministerio de Salud, Argentina.
Ramiro Dana SmithInstituto Nacional de Epidemiología Dr. Jara. ANLIS Malbran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: COVID-19 differentially affected individuals with chronic diseases such as cancer, with greater severity and mortality than the general population. Objetives: Estimate the incidence of infection, hospitalization and fatality due to COVID-19 in cancer patients diagnosed between January 1, 2018 and December 31, 2020, treated at a Hospital in the city of Mar del Plata and evaluate risk factors for infection. Methods: retrospective cohort study in cancer patients aged 15 years or older. Demographic variables, comorbidities, tumor characteristics, oncological treatments, infection, hospitalization and death due to COVID-19 were collected. Kaplan-Meier curves and a Cox regression model were fitted, the time until infection was the response variable. Results: 995 patients were included and 8.9% had COVID-19. 95.6% had solid tumors, 41.4% had severe forms of cancer, 1.7% had more than one malignant tumor and 10.9% had tumors with metastatic forms. Patients under 60 years of age, with hematological cancer and/or severe forms of cancer had significantly higher risk of COVID-19 infection. Discussion: The greater circulation and exposure in those under 60 years of age could explain the higher risk of infection, while the decrease in the immune status in the case of solid cancers with more severe stages or those of a hematological type could explain the higher risk.

Indexed as

COVID-19NeoplasmsAdolescentAdultAgedAged, 80 and overArgentinaComorbidityFemaleHospitalizationHumansIncidenceMaleMiddle AgedRetrospective StudiesRisk FactorsCOVID-19incidenceneoplasmsrisk factors

Identifiers

PMID41032432
PMCPMC12699784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.